Jo Liesenborghs

From January 2019 on General Manager for S&N Switzerland, for the Swiss organization, and additional Sales Director for Advanced Wound Care.

After 6 years, again with Smith&Nephew, BST cargel from Piramal was acquired by S&N for sports med. Today I am responsible for the sales and marketing wound care group in Switzerland. Beginning of 2017, I took ad interim for 4 months the general management position for S&N in Belgium, till the new in Belgium living GM was appointed.

Responsible for sales development of BST-cargel. Set the Strategic sales approach worldwide; define the country priorities and distribution by evaluating the market opportunities, the business plans, and registration and reimbursement parameters. Managing the direct sales team in Europeand defining distribution channels for non-direct markets.Setting up the centre of excellence concept with international champions. Push the multi-channel approach at professional and patient level.

Director Sales at Geistlich Surgery (Orthopeadics), Managing and building up the markets for the Business unit, with specialisation in Cartilage repair for the Hip, Knee and the ankle Joint, with a strong positioning in the sports medicine. Managing the direct markets, and distributors.The second product range, bone substitutes, with a positioning in the Orthopeadic, traumatology and maxillo facial market segment.

As member of the corporate business development group, responsible for the scientific and economical, project selection, evaluation and implementation of the Orthobiologics products within the orthopaedic market and their Marketing. Built from start a successful Business Unit with 27 Million Euro sales, with biological products for bone and tendon regeneration, with production in US and Mexico.

Responsibility for Europe, Asia, Australia and Africa. Leading a Group of 35 persons, divided over 5 divisions, in all 5 of them with product managers, development engineers and designers. Responsible for development- and marketing budget, reporting to the CMO

Responsible as team leader for the cement less hip portfolio ( Allopro, Protek) and computer navigated hip surgery, life cycle management, new developments, clinical trials, medical advisory boards and project monitoring. The international group was set together out of 4 product managers and 5 development engineers.

Within Bavaria responsible for sales portfolios of hip-, knee-, spine- and shoulder implants, trauma implants, arthroscopy and the power tools.